Dr. Monica Mechele Colvin, MD

Dr. Colvin practices at University Hospital in Ann Arbor, Michigan.

Dr. Colvin's NPI, 1457388431, was assigned on June 27, 2006. Dr. Colvin graduated from University of Alabama School of Medicine in 1995. Dr. Colvin holds Michigan license 4301106305.

Dr. Colvin's primary practice is University Hospital, at 1500 E Medical Center Dr, Ann Arbor, MI 48109. The practice phone is (734) 936-4000.

Dr. Colvin's primary practice is University Hospital in Ann Arbor, Michigan. Dr. Colvin is also affiliated with University Hospital. The medical group on file is University of Michigan Health. Dmand AI also links Dr. Colvin to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Colvin's employer is on file too: a school & student health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Colvin practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Colvin's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Colvin's licenses on file in 2 states: Michigan and Minnesota.

CMS data shows 245 Medicare services from Dr. Colvin across 5 procedure codes in 2024, for 77 Medicare patients. Medicare paid $23,664 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 77 Medicare patients who saw Dr. Colvin in 2024. The largest group is under 65, with 31 patients. 75% of them have heart failure, and 75% have high blood pressure. 44% are also on Medicaid. Their average risk score is 3.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Colvin's median patient age at 61, with 40% women.

In 2024, Dr. Colvin wrote 1,495 Medicare Part D claims for 124 patients. 79% of them were for generic drugs. CMS names the drug for 1,344 of them, across 31 drugs with 11 or more claims each, at $682,395 in total drug cost. In 2023, CMS named 1,513 claims across 31 drugs.

Dr. Colvin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Colvin as offering telehealth.

Dmand AI links 63 papers to Dr. Colvin, published from 2014 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Heart Transplantation, Heart Failure and Waiting Lists. Dr. Colvin has published most often in Am J Transplant. Dr. Colvin's most frequent co-authors are Ajay K. Israni, MD, Keith David Aaronson, MD and Jodi M. Smith.

Dmand AI links Dr. Colvin to 2 clinical trials. Conditions studied include Heart Diseases and Cardiovascular Diseases. CareDx sponsors the most, 2.

CMS Open Payments shows 25 general payments to Dr. Colvin from 6 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 40% of the total. Alnylam Pharmaceuticals Inc. paid the most, $3,690.

Dr. Colvin graduated from University of Alabama School of Medicine in 1995.